المؤلفون: Alireza Faridar, Abdulmunaim M. Eid, Aaron D. Thome, Weihua Zhao, David R. Beers, Maria B. Pascual, Mohammad O. Nakawah, Gustavo C. Roman, Charles S. Davis, Michael Grundman, Joseph C. Masdeu, Stanley H. Appel

مصطلحات موضوعية: Medicine, Microbiology, Physiology, Pharmacology, Immunology, Science Policy, Computational Biology, Information Systems not elsewhere classified, phase 1 open, label pilot study, https :// classic, retrospectively registered, dose interleukine, alzheimer ’, 2 immunotherapy

Relation: https://figshare.com/articles/journal_contribution/Additional_file_1_of_A_phase_1_open-label_pilot_study_of_low-dose_interleukine-2_immunotherapy_in_patients_with_Alzheimer_s_disease/24571810

الاتاحة: https://doi.org/10.6084/m9.figshare.24571810.v1
https://figshare.com/articles/journal_contribution/Additional_file_1_of_A_phase_1_open-label_pilot_study_of_low-dose_interleukine-2_immunotherapy_in_patients_with_Alzheimer_s_disease/24571810